Q3 2023 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2023-11-14 · accession 0001214659-23-015115
$317.0M
Reported value
13
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91529Y106 | UNM | UNUM GROUP | $42.7M | 13.5% | 867,565 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $37.2M | 11.7% | 129,917 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $37.1M | 11.7% | 113,178 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $32.0M | 10.1% | 129,163 | Common | SOLE |
| 194014502 | ENOV | ENOVIS CORPORATION | $26.5M | 8.36% | 502,731 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $26.4M | 8.32% | 98,126 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $24.7M | 7.79% | 96,115 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $21.3M | 6.71% | 428,452 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $17.7M | 5.59% | 469,405 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $15.4M | 4.87% | 568,544 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $15.4M | 4.86% | 570,682 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $12.3M | 3.89% | 389,791 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $8.3M | 2.61% | 313,381 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.